Pepbase

GHK-Cu Dosing, Cycle, and Tips

A comprehensive overview of common dosing protocols, cycle lengths, administration routes, and best practices for GHK-Cu.

GHK-Cu, also known as Copper Tripeptide-1, is commonly administered via subcutaneous injection and topical application. The injectable form is preferred for systemic effects, offering higher bioavailability and deeper tissue penetration, which is beneficial for anti-aging, wound healing, and hair growth [Doc 1, Doc 3]. Topical formulations, such as creams and serums, are widely used for skin rejuvenation and are convenient for daily use, though they provide limited systemic absorption compared to injections [Doc 6, Doc 8]. Each route has its specific advantages, with injections providing more potent effects and topicals being non-invasive and easy to incorporate into skincare routines [Doc 6, Doc 8].

Subcutaneous Injection

Subcutaneous injection of GHK-Cu is favored for its systemic effects, delivering the peptide directly into the bloodstream for widespread tissue repair and anti-aging benefits. This method ensures higher bioavailability compared to topical applications, making it suitable for significant regenerative goals like hair restoration and wound healing [Doc 1, Doc 3]. The standard protocol involves injecting 1-2 mg daily, with cycles typically lasting 8-12 weeks followed by a break to prevent copper accumulation [Doc 7]. While effective, injections require careful administration and monitoring for potential side effects such as skin irritation or copper toxicity [Doc 2, Doc 8].

Phase / ProtocolDosageFrequency
Standard1-2 mgdaily

Topical Application

Topical GHK-Cu is applied as creams or serums, targeting skin rejuvenation and minor wound healing. This route is non-invasive and easy to use, making it ideal for ongoing skincare routines. Topical formulations typically contain 2-4% GHK-Cu and are applied once or twice daily to areas of concern [Doc 6, Doc 8]. While convenient, the bioavailability is lower than injections, limiting systemic effects but effectively improving skin texture, elasticity, and reducing fine lines [Doc 5, Doc 6].

Phase / ProtocolDosageFrequency
Standard2-4%2x daily